Prescription Drugs Feed

Founder and executives of opioid company convicted of bribing doctors and lying to insurance companies to increase sales

The founder and four former executives of Insys Therapeutics Inc. were convicted Thursday by a federal jury in Boston of bribing medical practitioners to prescribe Subsys, a highly-addictive, fentanyl spray intended for cancer patients, and for defrauding Medicare and private insurance companies. John Kapoor, Insys founder and former chairman, and... Read more →


Drugs that cause uncontrollable behaviors like binging and gambling need stronger labeling, citizens group says

Public Citizen sued the U.S. Food and Drug Administration in federal court Monday over its failure to act on a nearly three-year-old petition seeking a boxed warning in the product labeling for widely used dopamine agonist medications, which can cause compulsive or uncontrollable behaviors. The 2016 petition called for black... Read more →


FDA should ban widely used, deadly gout medication, consumer group says

The U.S. Food and Drug Administration should immediately ban the widely used gout medication febuxostat because it poses unique, serious risks – including the risk of dying from cardiovascular disease – and provides no unique benefit, Dr. Michael Carome, director of Public Citizen’s Health Research Group, said Friday. Public Citizen... Read more →


Two more blood pressure medications recalled due to possible cancer risks

Teva Pharmaceuticals is recalling all lots of combination tablets featuring the drugs amlodipine and valsartan and another combination drug featuring amlodipine, valsartan, and hydrochlorothiazide due to an impurity detected. The impurity is N-nitroso-diethylamine or NDEA, which has been classified as a probable human carcinogen, according to the U.S. Food and... Read more →


Blood pressure medication recalled due to impurities that could cause cancer

ScieGen Pharmaceuticals Inc. is recalling some lots of Irbesartan tablets because they may be contaminated with an impurity. The impurity, N-nitrosodiethylamine, is classified as a probable human carcinogen by the International Agency for Research on Cancer. The Irbesartan tablets recalled include 75 mg., 150 mg., and 300 mg. dosages and... Read more →


Baby boomers focus on autumn opportunities

The weather here is changing, with temperatures dropping and brightly colored leaves beginning to pile up sidewalks so you can swish through them when you walk. There's a fall nip in the air, foreshadowing Halloween and the Day of the Dead – just around the corner. Our boomer bloggers are... Read more →


FDA considering approval of a super-potent opioid medication that will be abused and kill people, consumer group says

A U.S. Food and Drug Administration advisory committee has recommended approval of AcelRx Pharmaceuticals’ application for use of sufentanil sublingual tablets to treat moderate-to-severe acute pain in a medically supervised setting. It’s five to 10 times more potent than fentanyl and 1,000 times more potent than morphine. The committee voted... Read more →


Burger chains make little progress in serving beef raised without antibiotics

Two burger chains, Shake Shack and BurgerFi, are serving beef raised without the routine use of antibiotics. They were the only restaurants to earn an “A” in the fourth annual Chain Reaction scorecard developed by six consumer and environmental groups. The vast majority of hamburger chains – 22 of the... Read more →


Corporation to pay $625 million for distributing contaminated drugs, including cancer drugs

Forty-four states and the federal government have reached an agreement with drug distributor AmerisourceBergen Corp. for illegal distribution of adulterated and misbranded drugs. ABC will pay the states and the federal government $625 million, of which $99.9 million will go to the states’ Medicaid programs. “ABC placed corporate profits over... Read more →


Trump’s idea for reducing the costs of prescription drugs isn’t going to do much

U.S. Health and Human Services Secretary Alex Azar’s description recently of the Trump administration’s plan to lower prescription prices for Americans through Medicare negotiations is disappointing “Compared to what the federal government could do to make medicines affordable, these are the leftovers of the small potatoes,” said Peter Maybarduk, director... Read more →